B Cells Are Required to Generate Optimal Anti-Melanoma Immunity in Response to Checkpoint Blockade

Cancer statistics, 2020

(2020) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

B cells and tertiary lymphoid structures promote immunotherapy response

(2020) Beth A. Helmink et al.   NATURE

B Cells and Melanoma Pathogenesis

(2019) Lazaro E. Aira et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

B cell depletion or absence does not impede anti-tumor activity of PD-1 inhibitors

(2019) William Damsky et al.   Journal for ImmunoTherapy of Cancer

B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma

(2019) Johannes Griss et al.   Nature Communications

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Advances in Immunotherapy for Melanoma: A Comprehensive Review

(2017) Carmen Rodríguez-Cerdeira et al.   MEDIATORS OF INFLAMMATION

Tumor-associated B-cells induce tumor heterogeneity and therapy resistance

(2017) Rajasekharan Somasundaram et al.   Nature Communications

B Cell–Specific MHC Class II Deletion Reveals Multiple Nonredundant Roles for B Cell Antigen Presentation in Murine Lupus

(2015) Josephine R. Giles et al.   JOURNAL OF IMMUNOLOGY

Toward predicting metastatic progression of melanoma based on gene expression data

(2015) Yuanyuan Li et al.   Pigment Cell & Melanoma Research

B Cells Promote Tumor Immunity against B16F10 Melanoma

(2014) Tadahiro Kobayashi et al.   AMERICAN JOURNAL OF PATHOLOGY

Effective Innate and Adaptive Antimelanoma Immunity through Localized TLR7/8 Activation

(2014) Manisha Singh et al.   JOURNAL OF IMMUNOLOGY

B-lymphocyte tolerance and effector function in immunity and autoimmunity

(2013) Wasif N. Khan et al.   IMMUNOLOGIC RESEARCH

B cells assist allograft rejection in the deficiency of protein kinase c-theta

(2013) Wenwei Yan et al.   TRANSPLANT INTERNATIONAL

B Cell-Derived IL-15 Enhances CD8 T Cell Cytotoxicity and Is Increased in Multiple Sclerosis Patients

(2011) Raphael Schneider et al.   JOURNAL OF IMMUNOLOGY

Vaccine adjuvant activity of 3M-052: An imidazoquinoline designed for local activity without systemic cytokine induction

(2011) Dmitri Smirnov et al.   VACCINE

B Cells Are Required for Optimal CD4+ and CD8+ T Cell Tumor Immunity: Therapeutic B Cell Depletion Enhances B16 Melanoma Growth in Mice

(2010) D. J. DiLillo et al.   JOURNAL OF IMMUNOLOGY

A systematic review of humoral immune responses against tumor antigens

(2009) Miriam Reuschenbach et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY